+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Stomach Cancer Drug"

Gastric Cancer Drugs Market 2025-2029 - Product Thumbnail Image

Gastric Cancer Drugs Market 2025-2029

  • Report
  • May 2025
  • 217 Pages
  • Global
From
Oncology Drugs Market 2025-2029 - Product Thumbnail Image

Oncology Drugs Market 2025-2029

  • Report
  • March 2025
  • 222 Pages
  • Global
From
From
From
Loading Indicator

Stomach cancer, also known as gastric cancer, is a type of cancer that affects the lining of the stomach. Oncology drugs are used to treat this type of cancer, and the stomach cancer drug market is a subset of the larger oncology drug market. These drugs are used to treat both early and advanced stages of stomach cancer, and can be administered orally, intravenously, or through injections. They can also be used in combination with other treatments such as chemotherapy and radiation therapy. The stomach cancer drug market is highly competitive, with many companies developing and marketing drugs for the treatment of this type of cancer. Some of the major players in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to improve the treatment of stomach cancer. Show Less Read more